The Food and Drug Administration (FDA) has approved Lynkuet ® (elinzanetant) for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause.

While the trial met its primary endpoint, the FDA stated in its letter that the application could not be approved in its current form.

HealthDay News — Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases compared with sulfonylureas among adults with type 2 diabetes, ...

Odds of delirium up 41% for patients admitted to physicians in the highest versus lowest quartile of first-generation antihistamine prescribing.

Notably, in a post-hoc analysis which included adolescents who were diagnosed with severe AA less than 2 years before starting treatment, successful hair regrowth at 1 year was achieved in 80% and ...

The Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory ...

Recurrence-free survival was numerically higher with adjuvant pembrolizumab, but difference was not significant.

HealthDay News — Vaccination against herpes zoster (HZ) is associated with lower risks for heart disease, dementia, and mortality among adults aged 50 years and older, according to a study presented ...

The contaminated eggs came from Black Sheep Egg Company’s Arkansas processing plant and were distributed in Arkansas, Missouri and potentially other states ...

HealthDay News — For patients with inflammatory bowel disease (IBD), alterations in gut microbiota are associated with health-related quality of life (HRQoL) outcomes, according to a study published ...

“For over a decade, and as recently as August, FDA has fully evaluated the emerging scientific evidence and repeatedly concluded that the data do not support a causal association between acetaminophen ...